Precision medicine for patients with advanced biliary tract cancers: Updated results from the prospective MOSCATO trial

被引：0
|
作者：
Verlingue, L. [1 ]
Malka, D. [2 ]
Allorant, A. [3 ]
Massard, C. [1 ]
Ferte, C. [4 ]
Lacroix, L. [5 ]
Rouleau, E. [6 ]
Auger, N. [7 ]
Delahousse, J. [8 ]
Sun, R. [9 ]
de Baere, T. [10 ]
Tselikas, L. [11 ]
Ba, B. [12 ]
Scoazec, J-Y. [13 ]
Michiels, S. [14 ]
Boige, V. [15 ]
Ducreux, M. [15 ]
Soria, J-C.
Hollebecque, A. [1 ]
机构：
[1] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[2] Inst Cancerol Gustave Roussy, Digest Oncol, Villejuif, France
[3] Gustave Roussy, Biostatist, Villejuif, France
[4] Gustave Roussy, Head & Neck, Villejuif, France
[5] Inst Gustave Roussy, BMO, Villejuif, France
[6] Gustave Roussy, Dept Biol & Pathol Med, Villejuif, France
[7] Gustave Roussy Canc Campus Grand Paris, Biol & Pathol Dept, Villejuif, France
[8] Inst Cancerol Gustave Roussy, Pharmacol, Villejuif, France
[9] Inst Gustave Roussy, Radiotherapy Dept, Radi INSERM U1030, Villejuif, France
[10] Inst Gustave Roussy, Radiol, Villejuif, France
[11] Gustave Roussy, Radiol, Villejuif, France
[12] Inst Cancerol Gustave Roussy, Radiol, Villejuif, France
[13] Gustave Roussy Inst, Pathol, Villejuif, France
[14] Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France
[15] Inst Gustave Roussy, Gastrointestinal Unit, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
726P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
    Niger, Monica
    Nichetti, Federico
    Casadei-Gardini, Andrea
    Morano, Federica
    Pircher, Chiara
    Tamborini, Elena
    Perrone, Federica
    Canale, Matteo
    Lipka, Daniel B.
    Vingiani, Andrea
    Agnelli, Luca
    Dobberkau, Anna
    Huellein, Jennifer
    Korell, Felix
    Heilig, Christoph E.
    Pusceddu, Sara
    Corti, Francesca
    Droz, Michele
    Ulivi, Paola
    Prisciandaro, Michele
    Antista, Maria
    Bini, Marta
    Cattaneo, Laura
    Milione, Massimo
    Glimm, Hanno
    Koehler, Bruno C.
    Pruneri, Giancarlo
    Huebschmann, Daniel
    Froehling, Stefan
    Mazzaferro, Vincenzo
    Pietrantonio, Filippo
    Di Bartolomeo, Maria
    de Braud, Filippo
    MOLECULAR ONCOLOGY, 2022, 16 (14) : 2733 - 2746
  • [22] Impact of molecular profiling on survival in patients with advanced biliary tract cancers
    Antoun, L.
    Deneche, I.
    Boileve, A.
    Tarabay, A.
    Rouleau, E.
    El Rawadi, E.
    Eid, R.
    Lacroix, L.
    Valery, M.
    Boige, V.
    Dartigues, P.
    Bani, M.
    Smolenschi, C.
    Scoazec, J.
    Ducreux, M.
    Hollebecque, A.
    Malka, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S163 - S163
  • [23] Treatment of advanced biliary tract cancers: from chemotherapy to targeted agents
    Casolino, Raffaella
    Braconi, Chiara
    HEPATOMA RESEARCH, 2021, 7
  • [24] Randomized, multicenter phase II trial of CAP7.1 in patients with advanced biliary tract cancers.
    Pape, Ulrich-Frank
    Kasper, Stefan
    Sinn, Marianne
    Caca, Karel
    Kuhlmann, Jan
    Keilholz, Ulrich
    Vogel, Arndt
    Utku, Nalan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [25] Effect of clinical trial eligibility criteria on patient selection for advanced biliary tract cancers
    Walmsley, C. S.
    Ellis, H.
    Baiev, I.
    Reyes, S.
    Goyal, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S134 - S134
  • [26] Survival of older patients with advanced biliary tract cancers by disease site.
    Bobiak, Sarah
    Lubeck, Deborah P.
    Duryea, Jennifer
    Danese, Mark D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Combination immunotherapy with ipilimumab and nivolumab in patients with advanced biliary tract cancers.
    Klein, Oliver
    Kee, Damien
    Nagrial, Adnan
    Ben Markman
    Underhill, Craig
    Michael, Michael
    Lum, Caroline
    Behren, Andreas
    Palmer, Jodie
    Tebbutt, Niall C.
    Carlino, Matteo S.
    Cebon, Jonathan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Prognostic roles nutritional index in patients with resectable and advanced biliary tract cancers
    Zeng, Di
    Wen, Ning-Yuan
    Wang, Yao-Qun
    Cheng, Nan-Sheng
    Li, Bei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (06)
  • [29] Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
    Manne, Ashish
    Woods, Edward
    Tsung, Allan
    Mittra, Arjun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] MEZLOCILLIN PROPHYLAXIS IN BILIARY-TRACT SURGERY - RESULTS OF A RETROSPECTIVE AND A PROSPECTIVE TRIAL
    GRUBER, UF
    ELKE, R
    WIDMER, M
    INFECTION, 1982, 10 : S144 - S147
12345